
A custom mRNA cancer vaccine cut melanoma relapse or death by 42%.
One tumor. One recipe. A 42% lower relative risk.
These are the stories readers most often counted as progress.

One tumor. One recipe. A 42% lower relative risk.

Housing stability may be health care.

A prevention program built for men paired consent, empathy, alcohol-risk awareness, and bystander practice.

Six hospitals changed everyday anesthesia practice, lowering estimated emissions and anesthetic spending without worsening tracked outcomes.

London's new tunnel intercepted most of the storm-overflow volume its designers modeled for 2025.

The study will test whether clearing amyloid, then adding a second mechanism, can delay inherited Alzheimer's.

The first Afia Birago's puddle frogs ever born under human care are now hopping at London Zoo.

An EMA committee recommended a once-daily oral RAS inhibitor for eligible adults with metastatic pancreatic cancer.

A school challenge has engaged 3,500+ young people in 23 countries to redesign everyday plastic use.

A new WHO review says transmission now remains only in the remote cross-border Yanomami Focus Area shared by Brazil and Venezuela.

The 2026 count was the highest in Georgia’s statewide record. The long-run nesting trend has risen about 4% a year since the early 1990s.

Three mother-and-young pairs and two adolescent males passed health checks before being released into a protected 23,000-hectare forest.

Demand broke records. The emergency alerts did not arrive. Since 2023, Texas added 19.5 GW of solar and 16 GW of battery storage.

Eight practical modules help communities turn names, skills and local knowledge into a plan before the next disruption arrives.

Five years, a 27% decline, and a health system still pushing: Rwanda is pairing community care with faster records and referrals.

The first 33-megawatt block is earning revenue under a power-purchase agreement. Two more blocks are due to complete the 100-megawatt first phase.

The national estimate is up from 148–189 in 2022. A monitored tigress has raised three litters—nine cubs—and one daughter is already breeding.

SB 868 treats certified portable solar more like a household appliance: utilities may require a simple online registration, but not prior approval.

In a 10-person safety trial, an experimental optogenetic treatment produced clinically meaningful light-sensitivity gains in six participants. It did not restore normal sight.

More than 250 practitioners and community members helped shape a decision process for high-stakes conservation moves.

Ratu and Delilah are both due in May 2027.

The pollinators carried a precise biological treatment to as many as 88% of flowers.

Two fins. One layer of living muscle. A light to follow.

Old batteries, panels and blades are starting to feed the next buildout.